BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 141 filers reported holding BIOSCRIP INC in Q2 2014. The put-call ratio across all filers is 4.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $390,000 | +20.4% | 182,107 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $324,000 | -8.5% | 182,107 | -3.8% | 0.00% | 0.0% |
| Q3 2015 | $354,000 | -33.3% | 189,377 | +29.6% | 0.00% | 0.0% |
| Q2 2015 | $531,000 | -20.9% | 146,146 | -3.5% | 0.00% | 0.0% |
| Q1 2015 | $671,000 | -41.8% | 151,452 | -8.1% | 0.00% | -50.0% |
| Q4 2014 | $1,152,000 | +1.1% | 164,767 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,139,000 | -9.2% | 164,767 | -1.6% | 0.00% | 0.0% |
| Q2 2014 | $1,255,000 | +7.4% | 167,367 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $1,168,000 | -14.4% | 167,367 | +4.4% | 0.00% | -33.3% |
| Q4 2013 | $1,364,000 | -46.9% | 160,367 | -45.2% | 0.00% | -40.0% |
| Q3 2013 | $2,567,000 | -68.4% | 292,429 | -40.7% | 0.01% | -66.7% |
| Q2 2013 | $8,129,000 | – | 492,733 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coliseum Capital Management, LLC | 5,622,410 | $5,847,000 | 2.64% |
| NORTH TIDE CAPITAL, LLC | 8,500,000 | $8,840,000 | 1.51% |
| WYNNEFIELD CAPITAL INC | 3,700,000 | $3,848,000 | 1.39% |
| Alta Fundamental Advisers LLC | 2,330,774 | $2,424,000 | 1.20% |
| ARDSLEY ADVISORY PARTNERS LP | 6,350,000 | $6,604,000 | 1.09% |
| Camber Capital Management LP | 10,180,000 | $10,587,000 | 0.55% |
| PERKINS CAPITAL MANAGEMENT INC | 298,000 | $310,000 | 0.34% |
| Hawk Ridge Capital Management | 340,429 | $354,000 | 0.18% |
| Eidelman Virant Capital | 220,000 | $228,000 | 0.13% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 227,280 | $236,000 | 0.11% |